LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Oxyrane U.K. Ltd.
Headquarters:
Manchester, United Kingdom
Website:
http://www.oxyrane.com
Year Founded:
2006
Status:
Private
BioCentury
|
Dec 13, 2017
Distillery Therapeutics
Endocrine / Metabolic
Read More
BioCentury
|
Nov 14, 2017
Distillery Therapeutics
Endocrine / Metabolic
Read More
BioCentury
|
Jul 18, 2015
Company News
Management tracks
Read More
BioCentury
|
Jan 21, 2013
Company News
Oxyrane management update
Read More
BioCentury
|
Dec 13, 2012
Targets & Mechanisms
Muscling up on Myozyme
Read More
BioCentury
|
Dec 13, 2012
Distillery Techniques
Technology: Drug platforms
Read More
BioCentury
|
Dec 12, 2011
Product Development
Muscling in on Myozyme
Oxyrane aims to compete with Genzyme's Myozyme in Pompe's
Read More
BioCentury
|
Nov 21, 2011
Financial News
Oxyrane completes venture financing
Read More
BioCentury
|
Nov 18, 2011
Financial News
Oxyrane raises $26.5M in a series D
Read More
Items per page:
10
1 - 9 of 9